Stephanie Lewis: Unscripted

With a $30.9M rights offering, Rare Element Resources aims to advance its Wyoming project, a key piece in America's race for rare earth independence.

UBC's strategic acquisition of Evidinno creates a new powerhouse in biopharma evidence, combining global scale with AI-driven health economic insights.

Unveiled at CES 2026, the Palette 300 challenges the 3D printing market with a radical design that promises high-speed, multi-material prints with near-zero waste.

SUI Group's appointment of former CFTC Commissioner Brian Quintenz signals a strategic push for regulatory credibility and institutional crypto adoption.

With billions from Intel and Joby Aviation, Ohio is using CES 2026 to prove it's the new epicenter for advanced manufacturing, AI, and mobility.

With a key drug decision looming and a refocused strategy, Rocket Pharmaceuticals faces a critical audience at the J.P. Morgan Healthcare Conference.

Civinity now wholly owns workforce platform Valandinis in a €1.26M deal, signaling a major shift towards vertical integration in the Baltic construction market.

LightLink launches Stella, a new 'chain-abstracted' wallet designed to eliminate gas fees and complexity, paving the way for mainstream enterprise adoption.

Marketing CEO J Franco earns ABWA's top honor, highlighting her entrepreneurial journey and the growing influence of women in the digital economy.

As robotaxis and self-driving trucks go commercial, a new group from Seeing Machines aims to solve the critical human trust and safety challenge.

MENA's streaming leader Anghami doubles its subscribers after its OSN+ merger, but a $37M loss raises questions about its high-stakes growth strategy.

The regional bank sold $360M in low-yield securities, accepting a major one-time loss to reinvest for higher returns and a stronger 2026 outlook.

Commodity giant Mercuria secures copper and gold from Pucobre's El Espino mine with a $375M financing deal, betting big on Chile and green metals.

With a novel therapy from newborn heart cells, Secretome Therapeutics heads to J.P. Morgan to showcase its progress against intractable heart failure.

With its 'Results Your Way' plan, the fitness giant is rolling out personalized coaching, recovery zones, and Pilates to compete in a changing market.

Biomaterials firm Bolt Projects posts huge revenue gains and raises 2026 guidance, but a looming Nasdaq delisting threat casts a shadow on its future.

From industrial giant to boutique destination, discover how Yantai leveraged its unique climate to capture a third of China's wine market and global acclaim.

A unique partnership brings accessible genetic testing to Boca Raton, using a community race to empower families with critical health knowledge.

A new report shows record traffic to MEFA's financial aid tools, revealing how Massachusetts families are navigating soaring tuition and new aid rules.

Precious metals soar in 2025, with silver's 128% surge fueled by geopolitical turmoil, economic fears, and a booming demand from green tech and AI.